Abstract
The focus of this book has been on estimating the budget impact when adding new drugs to the current mix of drug treatments. The components that need to be completed when estimating the budget impact of other types of health care interventions are the same, but the approach needed for each component may be different. In this chapter, we provide an overview of differences in approach needed for estimating the budget impact of new vaccines, diagnostic tests, surgical procedures, and devices. We also present examples of budget-impact analyses that have been performed for these types of health care interventions.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aubry W, Lieberthal R, Willis A, Bagley G, Willis SM, Layton A. Budget impact model: epigenetic assay can help avoid unnecessary repeated prostate biopsies and reduce healthcare spending. Am Health Drug Benefits. 2013;6(1):15–24.
Babashov V, Palimaka S, Blackhouse G, O’Reilly D. Magnetic resonance-guided high-intensity focused ultrasound (MRgHIFU) for treatment of symptomatic uterine fibroids: an economic analysis. Ont Health Technol Assess Ser. 2015;15(5):1–61.
Carlton R, Mallick R, Campbell C, Raju A, O’Donnell T, Eaddy M. Evaluating the expected costs and budget impact of interventional therapies for the treatment of chronic venous disease. Am Health Drug Benefits. 2015;8(7):366–74.
Cassarino DS, Lewine N, Cole D, Wade B, Gustavsen G. Budget impact analysis of a novel gene expression assay for the diagnosis of malignant melanoma. J Med Econ. 2014;17(11):782–91.
Centers for Medicare and Medicaid Services. Physician fee schedule search. www.cms.gov/apps/physician-fee-schedule/search/search-criteria.aspx. Accessed 7 Mar 2014. Cited in: Carlton et al. 2015.
Health Quality Ontario. Paclitaxel drug-eluting stents in peripheral arterial disease: a health technology assessment. Ont Health Technol Assess Ser. 2015;15(20):1–62.
Mallick R, Raju AD, Campbell CM, Carlton R, Harmon J, Eaddy M. Evaluating treatment patterns, outcomes and costs in patients diagnosed with varicose veins. Poster presented at the International Society for Pharmacoeconomics and Outcomes Research 19th Annual International Meeting; 31 May–4 June 2014; Montréal. Cited in: Carlton et al. 2015.
Mauskopf J, Talbird S, Standaert B. Categorization of methods used in cost-effectiveness analyses of vaccination programs based on outcomes from dynamic transmission models. Expert Rev Pharmacoecon Outcomes Res. 2012;12(3):1–14.
Nelson HD, Tyne K, Nalk A, Bougatsos C, Chan BK, Humphrey L. Screening for breast cancer: an update for the US Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37. doi:10.7326/0003-4819-151-10-200911170-00009.
Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, et al.; Active Bacterial Core Surveillance Team. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States. Clin Infect Dis 2008;46(1):1–13. doi:10.1086/524041.
Talbird SE, Graham JB, Mauskopf JA, Masseria C, Krishnarajah G. Impact of tetanus, diphtheria, and acellular pertussis (Tdap) vaccine use in wound management on health care costs and pertussis cases. J Manag Care Pharm. 2015;21(1):88–99.
Thompson JR, Talbird SE, Mauskopf JA, Brogan AJ, Standaert B. Translating outcomes from a dynamic transmission model for vaccination to cost-effectiveness estimates: the impact of different analytic approaches on the results. Podium presentation at the ISPOR 17th Annual International Meeting; June 6, 2012; Washington, DC. [abstract] Value Health. 2012;15(4):A10.
USA Preventive Services Task Force. Screening for breast cancer: USA Preventive Services Task Force recommendation statement. Ann Intern Med. 2009;151(10):716–26. doi:10.7326/0003-4819-151-10-200911170-00008. Erratum in: Ann Intern Med. 2010;152(10):688. Ann Intern Med. 2010;152(3):199–200
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Mauskopf, J., Wolowacz, S., Earnshaw, S. (2017). Alternative Interventions. In: Budget-Impact Analysis of Health Care Interventions. Adis, Cham. https://doi.org/10.1007/978-3-319-50482-7_13
Download citation
DOI: https://doi.org/10.1007/978-3-319-50482-7_13
Published:
Publisher Name: Adis, Cham
Print ISBN: 978-3-319-50480-3
Online ISBN: 978-3-319-50482-7
eBook Packages: MedicineMedicine (R0)